QSAR Pharmacophore-based Virtual Screening, CoMFA and CoMSIA Modeling and Molecular Docking towards Identifying Lead Compounds for Breast Cancer Protease Inhibitors

Journal Title: Journal of Pharmaceutical Research International - Year 2017, Vol 20, Issue 1

Abstract

Aim: This study used QSAR Pharmacophore-based virtual screening and molecular docking to identify lead compounds and determine structural requirements for breast cancer inhibitor development. CoMFA and CoMSIA modeling was employed to design more potential inhibitors. Materials and Methods: 3D-QSAR pharmacophore models were developed using HypoGen Module and validated by Fischer’s model and decoy test. The best pharmacophore model was employed to screen ZINC chemical library to obtain reasonable hits. Following ADMET filtering, 18 hits were subjected to further filter through docking. CoMFA and CoMSIA models were built by partial least squares on phenylindole-3-carbaldehydes derivatives. Results: 19 random runs from Fischer’s validation and decoy test which led to an enrichment factor of 48.23 and Guner-Henry factor of 0.774 show that the identified pharmacophore model is highly predictive. Top three hits (IC50=0.01~0.05 µM, fitness =52~62) were identified as potential inhibitory candidates from virtual screening and docking, and three new lead compounds were designed with predicted inhibiting potencies by pIC50 value of 8.55 from CoMFA and CoMSIA modeling and fitness value of ~59 from docking. Conclusion: Validation results and decoy test indicate that the developed pharmacophore model is highly predictive. Residue Sep6 and Cys 5 were observed as important active sites for ligand-protein binding. Top three hits were identified as more potential inhibitors, and the designed compounds show more inhibiting potencies. The QSAR and docking results obtained from this work should be useful in determining structural requirements for inhibitor development as well as in designing more potential inhibitors.

Authors and Affiliations

Lan Huang, Xuan R. Zhang, Pei H. Luo, Lun Yuan, Xang Z. Zhou, X. Gao, Ling S. Li

Keywords

Related Articles

The Effect of Training Based on Precaution Adoption Process Model (PAPM) on Rural Females’ Participation in Pap smear

Background: Decision making for adopting a health behavior is a process involving passing through different stages. Objectives: This study was conducted to determine the decision-making stages based on Precaution Adoptio...

α-Glucosidase and α-Amylase Inhibitory Activities of Nine Sri Lankan Antidiabetic Plants

Aims: α-Amylase and α-glucosidase have been recognized as therapeutic targets for reduction of postprandial hyperglycaemia in diabetes mellitus. Objective of the study was to assess the α-amylase and α-glucosidase inhibi...

The Protective Effect of Calcitriol on Diabetic Neuropathy in STZ-induced Diabetic Rats

Diabetic peripheral neuropathy (DPN) is one of the diabetic complications that have a complex etiology and even with good glycemic control can have severe consequences. To date, there is no effective treatment for DPN. T...

Effect of Drying Methods on the Powder and Compaction Properties of Microcrystalline Cellulose Derived from Cocos nucifera

Aim: This work aims at investigating the effect of drying methods on the powder and compaction properties of microcrystalline cellulose (MCC) obtained from the matured fruit husk of Cocos nucifera (CN). Study Design: Ex...

QSAR Pharmacophore-based Virtual Screening, CoMFA and CoMSIA Modeling and Molecular Docking towards Identifying Lead Compounds for Breast Cancer Protease Inhibitors

Aim: This study used QSAR Pharmacophore-based virtual screening and molecular docking to identify lead compounds and determine structural requirements for breast cancer inhibitor development. CoMFA and CoMSIA modeling wa...

Download PDF file
  • EP ID EP313139
  • DOI 10.9734/JPRI/2017/37821
  • Views 99
  • Downloads 0

How To Cite

Lan Huang, Xuan R. Zhang, Pei H. Luo, Lun Yuan, Xang Z. Zhou, X. Gao, Ling S. Li (2017). QSAR Pharmacophore-based Virtual Screening, CoMFA and CoMSIA Modeling and Molecular Docking towards Identifying Lead Compounds for Breast Cancer Protease Inhibitors. Journal of Pharmaceutical Research International, 20(1), 1-10. https://europub.co.uk/articles/-A-313139